GTS Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
+747
| New | +$244K | 0.01% | 1017 |
|
|
2025
Q1 | – | Sell |
-1,163
| Closed | -$274K | – | 1225 |
|
|
2024
Q4 | $274K | Sell |
1,163
-7,040
| -86% | -$1.66M | 0.01% | 940 |
|
|
2024
Q3 | $2.26M | Buy |
8,203
+7,107
| +648% | +$1.95M | ﹤0.01% | 372 |
|
|
2024
Q2 | $266K | Buy |
+1,096
| New | +$266K | ﹤0.01% | 1251 |
|
|
2024
Q1 | – | Sell |
-1,966
| Closed | -$376K | – | 1409 |
|
|
2023
Q4 | $376K | Buy |
+1,966
| New | +$376K | ﹤0.01% | 1036 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1396 |
|